 Share the Science with Dr. Baumgartner: Focus on Stroke & Hearing Loss Latest Research on Using Cord Blood for Perinatal Stroke & Acquired Hearing Loss: On December 2nd, 2015, we had the pleasure to welcome Dr. James Baumgartner as our featured speaker on Share the Science. Dr. Baumgartner is the Surgical Director of the Comprehensive Pediatric Epilepsy Center at the Florida Hospital for Children. His presentation focused on preclinical data supporting the use of cord blood to treat acquired nervous system injury, and describe two ongoing clinical trials using autologous cord blood to treat acquired hearing loss and perinatal stroke in children. Dr. Baumgartner’s research is truly changing the way we do medicine. Normally, there are no reparative treatment options available for perinatal stroke or hearing loss acquired early in life. Instead, treatment is usually focused on management options to improve the function of the brain or injured cochlea. However, Dr. Baumgartner’s pre-clinical data suggests that progenitor cell infusions may allow for at least partial repair of these acquired central nervous system injuries. Human umbilical cord blood is an available stored progenitor cell population available for therapeutic use. In this webinar Dr. Baumgartner presents the pre-clinical data supporting the use of cord blood to treat acquired nervous system injury, and describe two ongoing clinical trials using autologous cord blood to treat acquired hearing loss and perinatal stroke in children. This webinar is now available in our archive.
Would you like to join us for our next Share the Science webinar? It’s easy. Simply click here and register. You can also enjoy free access to our full archive of previous presentations from leading experts like Dr. Joanne Kurtzberg from Duke, Michael Boo from NMDP, Kate Girard who is Director of Clinical Affairs at Viacord and many more.  |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
March 2023
Categories |
RSS Feed
